Full analysis of the effects and efficacy of upadatinib: side effects and how to deal with them

Upadacitinib is an oral Janus kinase (JAK) inhibitor, mainly used to treat inflammatory diseases caused by immune system abnormalities, such as atopic dermatitis (AD) and rheumatoid arthritis (RA). The drug reduces the inflammatory response by selectively inhibiting JAK1 and interfering with the signaling pathways of immune cells. Due to its role in targeting the immune system, upadatinib is able to effectively control symptoms and improve patients' quality of life.

Although upadatinib has significant clinical efficacy, it may also cause a series of side effects. The most common side effects include upper respiratory tract infection, headache, hypertension, and dyslipidemia. Because the drug suppresses inflammation by modulating the immune system, patients may be at risk of suppressed immune function while taking upadacitinib, increasing the chance of infection. Therefore, patients need to pay special attention to infection symptoms during use and report to the doctor in time.

In addition, upadatinib may have a certain impact on liver function, and some patients may experience elevated liver enzymes. Patients with liver function problems need to be particularly careful when using upadacitinib and have liver function tests performed regularly. In addition, long-term use of this drug may cause increased blood sugar or weight gain, and some patients may experience these metabolic-related problems during treatment.

For the management of side effects, patients should undergo regular physical examinations during the use of upadatinib, especially monitoring of blood pressure, liver function, blood lipids and other indicators. If infection or allergic reaction occurs, you should report it to your doctor in time and adjust the medication plan if necessary. At the same time, patients should avoid stopping medication or changing doses on their own, and all treatment adjustments should be made under the guidance of a doctor.

Reference materials:https://www.rinvoq.com/